PAMCX
Price
$104.12
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
PGOFX
Price
$49.50
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

PAMCX vs PGOFX

Header iconPAMCX vs PGOFX Comparison
Open Charts PAMCX vs PGOFXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$104.12
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Pioneer Select Mid Cap Growth A
Price$49.50
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PAMCX vs PGOFX Comparison Chart
Loading...
VS
PAMCX vs. PGOFX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a StrongBuy and PGOFX is a Buy.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31B vs. PGOFX (1.43B). PAMCX (0.00) and PGOFX (0.00) have matching dividends . PAMCX was incepted earlier than PGOFX: PAMCX (24 years) vs PGOFX (31 years). PGOFX is a more actively managed with annual turnover of: 72.00 vs. PAMCX (21.70). PGOFX has a lower initial minimum investment than PAMCX: PGOFX (1000) vs PAMCX (2500). PGOFX annual gain was more profitable for investors over the last year : 26.97 vs. PAMCX (10.53). PGOFX return over 5 years is better than : 13.08 vs. PAMCX (11.14).
PAMCXPGOFXPAMCX / PGOFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years31 years-
Gain YTD7.93614.66154%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets31B1.43B2,165%
Annual Yield % from dividends0.000.00-
Returns for 1 year10.5326.9739%
Returns for 3 years-16.76-20.3482%
Returns for 5 years11.1413.0885%
Returns for 10 years34.7414.69237%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COLL38.781.40
+3.75%
Collegium Pharmaceutical
PRU119.440.76
+0.64%
Prudential Financial
SMC37.000.22
+0.60%
Summit Midstream Corporation
ESGR318.86-2.64
-0.82%
Enstar Group Limited
ELEV0.59-0.01
-1.54%
Elevation Oncology